Skip to content
Forge Biologics
  • About
    • About
    • Mission & Approach
    • Leadership
    • Board
  • Services
    • Manufacturing Services
    • Technology
  • Science
    • Science
    • Pipeline
    • About Gene Therapy
    • FBX-101 for Krabbe Disease
  • Careers
  • News & Insights
    • News
    • Events
    • Insights
    • Media Kit
  • Connect

FBX-101

Forge Biologics Cleared for Clinical Trial of FBX-101, a Krabbe Disease Treatment
FDA Fast Track, ODD, and RPDD Designations for FBX-101 Gene Therapy for Patients with Krabbe Disease
FDA Clearance of Investigational New Drug for Patients with Krabbe Disease
United Leukodystrophy Foundation
RESKUE Trial for Patients with Krabbe Disease
FDA Clearance of Investigational New Drug for Patients with Krabbe Disease
Copyright Forge Biologics - All Rights Reserved Cookie Notice | Privacy Policy

I agree to the Cookie Notice and Privacy Policy

I agree